Prospective evaluation of small bowel preparation with bisacodyl and sodium phosphate for capsule endoscopy

Table 1 Patient’s data and indications for CE: Group A (fasting) and group B (additionally Prepacol^®)

	Group A	Group B	P value
Gender (w/m)	13/13	10/16	NS
Age (yr)	54 ± 17	56 ± 20	NS
Weight (kg)	71 ± 15	79 ± 17	NS
Length (cm)	170 ± 10	171 ± 8	NS
Indication
GI-bleeding	17 (65%)	19 (73%)	NS
Inflammatory bowel disease	4 (15%)	3 (12%)	NS
Miscellaneous	5 (19%)	4 (15%)	NS

Data are mean ± SEM; NS: Not significant.

Table 2 GI transit times: Group A (fasting) and group B (additionally Prepacol^®)

	Group A	Group B	P value
Gastric retention (min)	38 ± 23	44 ± 47	NS
Small bowel transit (min)	287 ± 97	262 ± 55	0.05
Total recording time (min)	441 ± 36	424 ± 49	NS

Data are mean ± SEM; NS: Not significant.